BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT-driven myeloid leukemia

Li Tzong Chen, Chiung Tong Chen, Weir Torn Jiaang, Tsai Yun Chen, Joseph H. Butterfield, Neng Yao Shih, John Tsu An Hsu, Hui You Lin, Sheng Fung Lin, Hui Jen Tsai

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT-driven myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences